Interaction of verotoxin 2e with pig intestine

Infection and Immunity

Volumn 64, Issue 5, 1996, Pages 1714-1719

  Waddell, Thomas E ^a,c   Lingwood, Clifford A ^b   Gyles, Carlton L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Health of Animals Laboratory   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VEROTOXIN; VEROTOXIN 2E;

ANIMAL TISSUE; ARTICLE; COLON; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; ILEUM; IMMUNOFLUORESCENCE; INTESTINE; INTESTINE BRUSH BORDER; INTESTINE CELL; JEJUNUM; MUCUS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SWINE; THIN LAYER CHROMATOGRAPHY;

EID: 0029922470     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.5.1714-1719.1996     Document Type: Article

References (43)

1. Bertschinger, H., and J. Pohlenz. 1983. Bacterial colonization and morphology of the intestine in porcine Estherichia coli enterotoxemia (edema disease). Vet Pathol 20:99-110.
2. Bertschinger, H. U., and N. O. Nielsen. 1992. Edema disease, p. 498-509. In A. D. Leman, B. E. Straw, W L Mengeling, D. J. Taylor, and S. D'Allaire (ed.), Diseases of swine, 7th ed Iowa State University Press, Ames.
3. Boyd, B., G. Tyrrell, M. Maloney, C. Gyles, J. Brunton, and C. Lingwood. 1993. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targeting and results in a verotoxin 1-like disease in pigs. J. Exp Med 177:1745-1753.
4. DeGrandis, S., H. Law, J. Brunton, C. Gyles, and C. A. Lingwood. 1989. Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264:12520-12525.
5. Farmer, J. J., M. E. Potter, L. W. Riley, T. J. Barrett, P. A. Blake, C. A. Bopp, M. L. Cohen, A. Kaufmann, G. K. Morris, R. S. Remis, B. M. Thomason, and J. G. Wells. 1983. Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis. Lancet i:702-703.
6. Folch, J., M. Lees, and G. H. Sloane-Stanely. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem 226:497-509.
7. Fuchs, G., M. Mobassaleh, A. Donohue-Rolfe, R. T. Montgomery, R. J. Grand, and G. T. Keusch. 1986. Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. Infect Immun. 53:372-377.
8. Gannon, V., and C. Gyles. 1990. Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease. Vet. Microbiol 24:89-100.
9. Gyles, C. L. 1992 Escherichia coli cytotoxins and enterotoxins. Can. J. Microbiol. 38:734-746.
10. Gyles, C. L. 1995. VT toxemia in animal models, p. 233-240 In M A. Karmali and A. G. Goglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
11. Kandel, G., A. Donobue-Rolfe, M. Donowitz, and G. T. Keusch. 1989. Pathogenesis of shigella diarrhoea. XVI. Selective targeting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J. Clin. Invest. 84:1509-1517.
12. Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol. Rev. 2:15-38.
13. Keenan, K. P., D. D. Sharpnack, H. Collins, S. B. Formal, and A. D. O'Brien. 1986. Morphologic evaluation of the effects of shiga toxin and E. coli shiga-like toxin on the rabbit intestine. Am. J. Pathol. 125:69-80
14. Kessler, M., O. Acuto, C. Storelli, H. Murer, M. Muller, and G. Semenza. 1978. A modified procedure of the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Biochim. Biophys. Acta 506:136-154.
15. Keusch, G. T., G. F. Grady, A. Takeuchi, and H. Sprinz. 1972. The pathogenesis of Shigella diarrhea. II. Enterotoxin induced acute enteritis in the rabbit ileum J Infect Dis 126:92-95
16. Keusch, G. T., M. Jacewicz, D. W. K. Acheson, A. Donohue-Rolfe, A. V. Kane, and R. H. McCluer. 1995. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 63:1138-1141
17. Keusch, G. T., M. Jacewicz, M. Mobassaleh, and A. Donohue-Rolfe. 1991. Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects. Rev Infect. Dis. 13:S304-S310.
18. Kurtz, H. J., M. E. Bergeland, and D. M. Barnes. 1969. Pathologic changes in edema disease of swine. Am. J. Vet. Res. 30:791-806.
19. Li, Z., C. Bell, A. Buret, R. Robins-Browne, D. Stiel, and E. O'Loughlin. 1993. The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits. Gastroenterology 104:467-474
20. Lindberg, A., J. E. Brown, N. Stromberg, M. Westling-Ryd, J. E. Schultz, and K. A. Karlsson. 1987 Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1 J Biol. Chem. 262:1779-1785.
21. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De-Grandis, and M. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262:8834-8839.
22. MacLeod, D. L., and C. L. Gyles. 1990. Purification and characterization of an Escherichia coli Shiga-like toxin II variant. Infect. Immun. 58:1232-1239.
23. MacLeod, D. L., C. L. Gyles, A. Valdivieso-Garcia, and R. C. Clarke. 1991. Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant Infect Immun. 59:1300-1306.
24. MacLeod, D. L., C. L. Gyles, and B. P. Wilcock. 1991. Reproduction of edema disease of swine with purified Shiga-like toxin-II variant Vet Pathol. 28:66-73
25. Methyiapun, S., J. F. L. Pohlenz, and H. U. Bertschinger. 1984. Ultrastructure of the intestinal mucosa in pigs experimentally inoculated with an edema disease-producing strain of Escherichia coli (0139-K12-H1). Vet Pathol. 21:516-520.
26. Mobassaleh, M., A. Donohue-Rolfe, M. Jacewicz, R. J. Grand, and G. T. Keusch. 1988. Pathogenesis of shigella diarrhea, evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. J. Infect. Dis 157:1023-1031
27. Mobassaleh, M., S. K. Gross, R. H. McCluer, A. Donohue-Rolfe, and G. T. Keusch. 1989 Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin Gastroenterology 97:384-391.
28. Pai, C. H., J. K. Kelly, and G. L. Meyers. 1986. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect. Immun. 51: 16-23
29. Potter, M. E., A. F. Kaufmann, B. M. Thomason, P. A. Blake, and J. J. Farmer. 1985. Diarrhea due to Escherichia coli O157:H7 in the infant rabbit J. Infect. Dis. 152:1341-1343.
30. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric, N. F. Olivieri, and M. A. Karmali. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
31. Samuel, J. L., P. Perera, S. Ward, A. D. O'Brien, V. Ginsberg, and H. C. Krivan. 1990. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun. 58: 611-618.
32. Sjogren, R., R. Neill, D. Rachmilewitz, D. Fritz, J. Newland, D. Sharpnack, C. Colleton, J. Fondacaro, P. Gemske, and E. Boedeker. 1994 Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 106:306-317.
33. Smith, H. W., and S. Halls. 1968 The production of oedema disease and diarrhea in weaned pigs by oral administration of Escherichia coli: factors that influence the course of experimental disease. J. Med Microbiol. 1:45 59.
34. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
35. Tyrrell, G. J. 1992. Studies of the glycosphingolipid binding specificity of pig edema disease toxin. Ph D thesis University of Toronto, Toronto, Ontario, Canada.
36. Waddell, T., A. Cohen, and C. Lingwood. 1990 Reconstitution of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc. Natl Acad. Sci. USA 87:7898-7901.
37. Waddell, T., S. Head, M. Petric, A. Cohen, and C. A. Lingwood. 1988. Globotriaosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152:674-678.
38. Waddell, T. E., and C. L. Gyles. 1995. Sodium deoxycholate facilitates systemic absorption of VT2e from pig intestine Infect. Immun. 63:4953-4956.
39. 38a.Waddell, T., C. A. Lingwood, and C. L. Gyles. 1994. Interaction of VT2e with pig intestine, p. 185-189. In M. A Karmali and A. G. Ooglio (ed.), Recent advances in verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
40. Walker, W. A. 1987. Pathophysiology of intestinal uptake and absorption of antigens in food allergy. Ann. Allergy 59:7-16.
41. Weiser, M. M. 1973. Intestinal epithelial cell surface membrane glycoprotein synthesis I. An indicator of cell differentiation. J. Biol. Chem. 248:2536-2541.
42. Westrom, B. R., J. Svendsen, B. G. Ohlsson, C. Tagesson, and B. W. Karlsson. 1984. Intestinal transmission of macromolecules (BSA and FITC-labeled dextrans) in the neonatal pig: influence of age of piglet and molecular weight of markers. Biol Neonate 46:20-26.
43. Zoja, C., D. Corna, C. Farina, G. Sacchi, C. Lingwood, M. P. Doyle, V. V. Padhye, M. Abbate, and G. Remuzzi. 1992. Verotoxin glycolipid receptors determine the localization of microangiopathic processes in rabbit given verotoxin-1. J. Lab. Clin. Invest. 120:229-238.